Cameron J. Turtle
Impact in
- Oncology top 0.05%
- CAR-T cell therapy research
- Immunology top 0.5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Oncology 148
- CAR-T cell therapy research 141
- Immunology 61
- Immune Cell Function and Interaction 25
- Biosimilars and Bioanalytical Methods 24
- Immunotherapy and Immune Responses 21
- Co-authors
- Stanley R. Riddell (72 shared papers)David G. Maloney (75 shared papers)Laïla‐Aïcha Hanafi (16 shared papers)Kevin A. Hay (20 shared papers)Sindhu Cherian (14 shared papers)Juliane Gust (7 shared papers)Daniel Li (7 shared papers)Xueyan Chen (13 shared papers)
- Journals
- Blood (59 papers)Transplantation and Cellular Therapy (10 papers)Blood Advances (10 papers)Journal of Clinical Oncology (9 papers)Biology of Blood and Marrow Transplantation (7 papers)
- Partner nations
- United StatesAustraliaSouth Africa
In The Last Decade
Cameron J. Turtle
160 papers receiving 12.1k citations
Cameron J. Turtle's Hit Papers
Peers
Comparison fields: 5 of 122
- Oncology 8.7k
- Immunology 3.6k
- Hematology 948
- Genetics 2.2k
- Genetics 726
Countries citing papers authored by Cameron J. Turtle
This map shows the geographic impact of Cameron J. Turtle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cameron J. Turtle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cameron J. Turtle more than expected).
Fields of papers citing papers by Cameron J. Turtle
This network shows the impact of papers produced by Cameron J. Turtle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cameron J. Turtle. The network helps show where Cameron J. Turtle may publish in the future.
Co-authors
The 25 scholars most cited alongside Cameron J. Turtle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 172 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells Hit paper breakdown → | 2017 | 993 |
| 2 | Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy Hit paper breakdown → | 2017 | 808 |
| 3 | Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells Hit paper breakdown → | 2009 | 795 |
| 4 | Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 + and CD4 + CD19-specific chimeric antigen receptor–modified T cells Hit paper breakdown → | 2016 | 775 |
| 5 | Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo Hit paper breakdown → | 2015 | 671 |
| 6 | Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy Hit paper breakdown → | 2016 | 575 |
| 7 | Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes Hit paper breakdown → | 2020 | 565 |
| 8 | Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor–Modified T Cells After Failure of Ibrutinib Hit paper breakdown → | 2017 | 506 |
| 9 | HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells Hit paper breakdown → | 2017 | 483 |
| 10 | Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy Hit paper breakdown → | 2017 | 406 |
| 11 | 2010 | 289 | |
| 12 | 2019 | 259 | |
| 13 | Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure Hit paper breakdown → | 2020 | 234 |
| 14 | Immunogenicity of CAR T cells in cancer therapy Hit paper breakdown → | 2021 | 223 |
| 15 | 2010 | 218 | |
| 16 | 2013 | 208 | |
| 17 | 2018 | 187 | |
| 18 | 2020 | 186 | |
| 19 | 2020 | 169 | |
| 20 | 2011 | 159 |
About Cameron J. Turtle
Cameron J. Turtle is a scholar working on Oncology, Immunology, Molecular Biology, Electrical and Electronic Engineering and Genetics, having authored 172 papers that have together received 12.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (141 papers), Immune Cell Function and Interaction (25 papers), Biosimilars and Bioanalytical Methods (24 papers), Virus-based gene therapy research (22 papers), Immunotherapy and Immune Responses (21 papers), Advancements in Semiconductor Devices and Circuit Design (17 papers), Viral Infectious Diseases and Gene Expression in Insects (16 papers) and Silicon Carbide Semiconductor Technologies (15 papers). The work is most often cited by research in Oncology (8.7k citations), Immunology (3.6k citations), Hematology (948 citations), Genetics (2.2k citations) and Genetics (726 citations). Cameron J. Turtle has collaborated with scholars based in United States, Australia and South Africa. Frequent co-authors include Stanley R. Riddell, David G. Maloney, Laïla‐Aïcha Hanafi, Kevin A. Hay, Sindhu Cherian, Juliane Gust, Daniel Li, Xueyan Chen, Michael Hudecek and Alexandre V. Hirayama. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Blood Advances, Journal of Clinical Oncology and Biology of Blood and Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.